Professor Cynthia Pine, BDS, MBA (Distinction), PhD, FDSRCS (Eng), CBE, FCGI
Professor of Dental Public Health; Academic Lead for Dental Public Health at the Institute of Dentistry
Email: email@example.comTelephone: 44(0)207 882 8636Room Number: Institute of Dentistry
Professor of Dental Public Health, Institute of Dentistry, School of Medicine and Dentistry
Academic Lead for Dental Public Health at the Institute of Dentistry
Honorary Consultant in Dental Public Health, Barts Health NHS Trust
Honorary Academic Consultant in Dental Public Health, Public Health England
Consultant in Dental Public Health, Salford Royal NHS Foundation Trust
Chair of the North West Committee of the NIHR Research for Patient Benefit Committee
Recent Previous Appointments
2010 – 2012 Pro Vice Chancellor (International) University of Salford
2008 – 2012 Dean of Health & Social Care, University of Salford
2003 - 2008 Dean of Dentistry, University of Liverpool
2003 – 2013 Director of the WHO Collaborating Centre for Research in Oral Health of Deprived Communities
Professor Pine has undertaken and supported national and international developments and collaborations in dental research through her own research and through elected office as: the first woman President of the British Association for the Study of Community Dentistry (BASCD); as Secretary General and Co-President of the European Organisation of Caries Research (ORCA); as Founding President of the European Association of Dental Public Health (EADPH) and through the International Association of Dental Research (IADR) as President of the Cariology Group. She was appointed Dean of Dentistry at the University of Liverpool in 2003, the first woman ever to be appointed to head a Dental School in the UK. Her contribution to research, science and education has been recognised by several bodies including: the American Association of Public Health Dentistry: Special Merit Award for Outstanding Achievement in Community Dentistry – Internationalin 2005; by theGovernment of Guyana, her country of birth, in 2006, when she was named as Outstanding Guyanese of the Year; by the Queen when she was appointed CBE in 2006; by inclusion in the Powerlist of the UK’s 100 most influential people of African and Afro-Caribbean descent. Most recently, she has been appointed to Fellowship of the City and Guilds of London Institute in March, 2014.
Specialist Training in Dental Public Health
Professor Pine is on the GDC Specialist List in Dental Public Health and was first appointed Consultant in 1993. She has been involved in training and specialist public health duties since then as both an Honorary Consultant in Dental Public Health and as a substantive Consultant within the NHS, and latterly as Honorary Academic Consultant to Public Health England. Currently, she is the Lead Academic Trainer for the NIHR Speciality Registrar in Dental Public Health established at the Institute of Dentistry with the London Deanery.
Research Administrator: Teresa Parker
Professor Pine’s research focus is on the prevention of childhood dental caries, taking a population community approach aligned with enhancing parental self-efficacy for dental health related behaviours. Her research is multi-disciplinary with partners in health and clinical psychology, biostatistics, health economics, linguistics and school education. She has considerable expertise in community clinical trials of caries prevention for children. Professor Pine has been invited to present her research in many countries and universities including at Harvard in the USA, the Karolinska in Sweden and the World Health Organisation in Geneva.
Randomised controlled trials
Professor Pine has active research grants of over £1,000,000 and is the Principal Investigator of three current clinical trials (as at June 2014); two as an NIHR Investigator: Bright Smiles Baby (NIHR: PB-PG-0808-17228); Dental RECUR (NIHR: PB-PG-0610-22310); and, the third as Principal Investigator of the BBaRTS randomised controlled trial: Bedtime Brush and Read Together to Sleep which is funded by an educational grant from GlaxoSmithKline.